Spots Global Cancer Trial Database for childhood hepatoblastoma
Every month we try and update this database with for childhood hepatoblastoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Chemotherapy in Treating Children With Liver Cancer | NCT00003912 | Liver Cancer | carboplatin cisplatin doxorubicin hyd... conventional su... | - 16 Years | National Cancer Institute (NCI) | |
| Irinotecan in Treating Young Patients With Refractory or Recurrent Hepatoblastoma | NCT00287976 | Liver Cancer | irinotecan hydr... | - 20 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer | NCT00003994 | Childhood Hepat... Recurrent Child... Stage I Childho... | therapeutic con... cisplatin vincristine sul... fluorouracil amifostine trih... carboplatin | - 21 Years | Children's Oncology Group | |
| Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma | NCT00077389 | Liver Cancer | carboplatin cisplatin doxorubicin hyd... adjuvant therap... conventional su... neoadjuvant the... | - 17 Years | National Cancer Institute (NCI) | |
| Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma | NCT00077389 | Liver Cancer | carboplatin cisplatin doxorubicin hyd... adjuvant therap... conventional su... neoadjuvant the... | - 17 Years | National Cancer Institute (NCI) | |
| Biomarkers in Tissue Samples From Young Patients With Liver Cancer | NCT01336881 | Childhood Hepat... Stage I Childho... Stage II Childh... Stage III Child... Stage IV Childh... | RNA analysis gene expression... microarray anal... nucleic acid se... diagnostic labo... | - 16 Years | Children's Oncology Group | |
| Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer | NCT01132547 | Cancer | cyproheptadine ... placebo | 2 Years - 21 Years | University of South Florida | |
| Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy | NCT00716976 | Brain Tumor Central Nervous... Childhood Germ ... Extragonadal Ge... Liver Cancer Neuroblastoma Ototoxicity Ovarian Cancer Sarcoma | sodium thiosulf... examination | 1 Year - 18 Years | Children's Oncology Group | |
| Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer | NCT01353300 | Brain and Centr... Hereditary Wilm... Kidney Cancer Liver Cancer Neuroblastoma Pleuropulmonary... Sarcoma | DNA analysis cytogenetic ana... gene expression... gene rearrangem... mutation analys... polymerase chai... polymorphism an... laboratory biom... medical chart r... | - 120 Years | Children's Oncology Group | |
| Biomarkers in Tissue Samples From Young Patients With Liver Cancer | NCT01336881 | Childhood Hepat... Stage I Childho... Stage II Childh... Stage III Child... Stage IV Childh... | RNA analysis gene expression... microarray anal... nucleic acid se... diagnostic labo... | - 16 Years | Children's Oncology Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
